• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.

作者信息

Pirotte J, Guffens J M, Devos J

出版信息

Digestion. 1974;10(6):435-44. doi: 10.1159/000197556.

DOI:10.1159/000197556
PMID:4448315
Abstract
摘要

相似文献

1
Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.慢性门体性脑病患者基础动脉血氨水平及口服诱导高氨血症的比较研究，采用新霉素、乳果糖以及新霉素与乳果糖联合治疗。
Digestion. 1974;10(6):435-44. doi: 10.1159/000197556.
2
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.乳果糖治疗慢性门体性脑病。一项双盲临床试验。
N Engl J Med. 1969 Aug 21;281(8):408-12. doi: 10.1056/NEJM196908212810803.
3
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.乳果糖与新霉素治疗慢性门体性脑病的比较。一项双盲对照试验。
Gastroenterology. 1977 Apr;72(4 Pt 1):573-83.
4
[Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
Med Klin. 1978 Jan 13;73(2):63-8.
5
[Treatment of chronic porto-systemic encephalopathy with lactulose].
Schweiz Med Wochenschr. 1969 Apr 19;99(16):584.
6
Portal systemic encephalopathy--should lactulose and neomycin be used together.
Br J Clin Pract. 1981 Sep;35(9):323-4.
7
Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
Am J Med. 1971 Aug;51(2):148-59. doi: 10.1016/0002-9343(71)90233-6.
8
[Lactulose in the therapy of porto-systemic encephalopathy].
Minerva Med. 1973 Dec 5;64(87):4596-603.
9
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.新霉素-山梨醇和乳果糖治疗急性门体性脑病：一项对照双盲临床试验
Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.
10
Long-term treatment of portal-systemic encephalopathy with lactulose.
Australas Ann Med. 1969 May;18(2):117-23. doi: 10.1111/imj.1969.18.2.117.

引用本文的文献

1
Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis.使用定量模型阐明肝脏、肠道、肾脏和肌肉在氨稳态中的作用以及乳果糖和利福昔明如何改变这种稳态。
Int J Gen Med. 2019 Oct 14;12:367-380. doi: 10.2147/IJGM.S218405. eCollection 2019.
2
Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.幽门螺杆菌根除治疗对肝硬化患者高氨血症的影响。
Gut. 1997 Jun;40(6):726-30. doi: 10.1136/gut.40.6.726.
3
Progress in the treatment of chronic portasystemic encephalopathy.
慢性门体分流性脑病的治疗进展
Gut. 1984 Jan;25(1):85-98. doi: 10.1136/gut.25.1.85.
4
Interactions of lactulose and neomycin.
Drugs. 1972;4(1):4-6. doi: 10.2165/00003495-197204010-00002.
5
Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.乳果糖：对其治疗和药理特性的综述，特别提及氨代谢及其在门体性脑病中的作用方式。
Drugs. 1972;4(1):7-48. doi: 10.2165/00003495-197204010-00003.
6
Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.
Klin Wochenschr. 1991 Feb 6;69(3):112-20. doi: 10.1007/BF01795954.
7
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.新霉素-山梨醇和乳果糖治疗急性门体性脑病：一项对照双盲临床试验
Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.